Member Price: $25.00
Title: 2024 DEA and Opioid Alternatives
Description:
This webinar will cover Opioid Alternatives as it relates to clinical practice challenges, mitigating risk and it will walk through case studies. It will also cover biopsychosocial approaches to care: non-opioid pharmacology, non-pharmacologic therapies and patient education.
Presenter: Dr. Kathileen Boozer, DNP, MSN, APRN, FNPC
Dr. Boozer is an owner operator of Inspired Skin+Wellness | Dermatology Clinic. She completed a dermatology internship in 2014 and has been practicing as a specialist in this field since. Dr. Boozer has a broad background in nursing with specific training and expertise in dermatology, skin cancer/ melanoma, and community health/education. She is an active member of transdisciplinary research teams investigating the use of virtual simulation technology for prevention and early diagnosis of skin cancer and community-based wellness initiatives to improve socialization, healthy habits, and health in rural India.
Release Date: February 15, 2024
Expiration Date: February 15, 2026
Learner Outcomes:
- Learner will change their current practice strategies to include measures discussed in this educational offering thus optimizing patient outcomes.
- Learner will detail strategies
to utilize to minimize patient harm related to abuse or misuse including using less risky treatment options prior to prescribing opioid medications.
Accreditation:
Learners will be awarded 1 Contact Hour, including 1 toward the DEA requirement. Completion of the course and evaluation are required.
Provider Statement:
Texas Nurse Practitioners is approved as a provider of nursing continuing professional development by Louisiana State Nurses Association Approver Unit, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. LSNA Provider No. 4003232
Disclosures:
No disclosures exist for presenters or Nurse Planners of this Educational Activity
